Track the OncoMed Pharmaceuticals Inc stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 12 January 2016 (Levée d'options). Among the most active insiders: Dupont Jakob. All data is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
21 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
OncoMed Pharmaceuticals Inc es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Se especializa en el descubrimiento y desarrollo de fármacos dirigidos a las células madre tumorales.